(NYSE: MDT) is on a roll in more than one way. The medical device giant is beating the S 500 since the start of 2023. The company also continues to strengthen its portfolios, winning more than 150 product clearances over the past year. And Medtronic is making big moves into the exciting field of Artificial Intelligence (AI).
At the same time, Medtronic has grown its dividend over time, making it a top dividend stock to own. Still, the company has faced economic headwinds -- and isn't growing in leaps and bounds. Is Medtronic stock a buy now? Let's find out.
First, a bit of background on Medtronic. The company sells devices globally in the areas of cardiovascular, neuroscience, diabetes, and surgery. Over time, Medtronic has increased net income, revenue, and free cash flow.
Source Fool.com